Coccidioidomycosis in Latin America
- PMID: 30690597
- DOI: 10.1093/mmy/myy037
Coccidioidomycosis in Latin America
Abstract
Coccidioidomycosis is a highly prevalent systemic mycosis in Latin America and has been reported (human and zoonotic cases) in México, Guatemala, Honduras, Colombia, Venezuela, Brazil, Paraguay, Bolivia, and Argentina. The incidence of coccidioidomycosis in Latin America is unknown due to lack of clinical awareness and limited access to laboratory diagnosis. Coccidioidomycosis is as prevalent in Mexico as in the endemic regions of the United States. The number of cases reported in Brazil and Argentina has progressively increased during the last decade, including areas that were not considered as endemic. Genetic studies have shown that the prevalent species in Latin America is Coccidioides posadasii. Coccidioides immitis has been reported sporadically in indigenous cases from Mexico and Colombia. Coccidioidomycosis and tuberculosis share some risk factors such as immunosuppression and residing in areas endemic for these conditions, so their coexistence in the same patient is not uncommon in Latin America. In most regions, clinical diagnosis of coccidioidomycosis is based on direct sputum examination and histopathology results from biopsies or autopsies. This would explain why primary coccidioidomycosis is rarely diagnosed, and most cases published are about chronic pulmonary or disseminated disease.
Similar articles
-
Primary Cutaneous Coccidioidomycosis: An Update.Am J Clin Dermatol. 2020 Oct;21(5):681-696. doi: 10.1007/s40257-020-00525-z. Am J Clin Dermatol. 2020. PMID: 32557380 Review.
-
The mysterious desert dwellers: Coccidioides immitis and Coccidioides posadasii, causative fungal agents of coccidioidomycosis.Virulence. 2019 Dec;10(1):222-233. doi: 10.1080/21505594.2019.1589363. Virulence. 2019. PMID: 30898028 Free PMC article. Review.
-
Molecular identification of Coccidioides immitis in formalin-fixed, paraffin-embedded (FFPE) tissues from a Colombian patient.Med Mycol. 2015 Jun;53(5):520-7. doi: 10.1093/mmy/myv019. Epub 2015 Apr 23. Med Mycol. 2015. PMID: 25908652
-
Molecular markers in the epidemiology and diagnosis of coccidioidomycosis.Rev Iberoam Micol. 2014 Jan-Mar;31(1):49-53. doi: 10.1016/j.riam.2013.09.011. Epub 2013 Nov 20. Rev Iberoam Micol. 2014. PMID: 24270069 Review.
-
[Historical evolution of some clinical and epidemiological knowledge of coccidioidomycosis in the Americas].Rev Argent Microbiol. 2008 Oct-Dec;40(4):246-56. Rev Argent Microbiol. 2008. PMID: 19213250 Spanish.
Cited by
-
Epidemiological, clinical, and genomic landscape of coccidioidomycosis in northeastern Brazil.Nat Commun. 2024 Apr 12;15(1):3190. doi: 10.1038/s41467-024-47388-0. Nat Commun. 2024. PMID: 38609393 Free PMC article.
-
Risk of Coccidioidomycosis Infection Among Individuals Using Biologic Response Modifiers, Corticosteroids, and Oral Small Molecules.ACR Open Rheumatol. 2024 May;6(5):287-293. doi: 10.1002/acr2.11654. Epub 2024 Feb 29. ACR Open Rheumatol. 2024. PMID: 38425143 Free PMC article.
-
Bat-associated microbes: Opportunities and perils, an overview.Heliyon. 2023 Nov 18;9(12):e22351. doi: 10.1016/j.heliyon.2023.e22351. eCollection 2023 Dec. Heliyon. 2023. PMID: 38125540 Free PMC article. Review.
-
Clinical Cases of Coccidioidomycosis in the Americas in the Period 1950-2021: Epidemiology Data, Diagnosis, and Treatment.Life (Basel). 2023 Oct 24;13(11):2109. doi: 10.3390/life13112109. Life (Basel). 2023. PMID: 38004249 Free PMC article. Review.
-
Diagnosis and Treatment of Pulmonary Coccidioidomycosis and Paracoccidioidomycosis.J Fungi (Basel). 2023 Feb 7;9(2):218. doi: 10.3390/jof9020218. J Fungi (Basel). 2023. PMID: 36836333 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical